Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Methodologic considerations for noninterventional studies of switching from reference biologic to biosimilars.

Desai RJ, Kim SC, Curtis JR, Bosco JLF, Eichelberger B, Barr CE, Lockhart CM, Bradbury BD, Clewell J, Cohen HP, Gagne JJ; Biologics and Biosimilars Collective Intelligence Consortium (BBCIC) Switching Workgroup.

Pharmacoepidemiol Drug Saf. 2019 Jul 12. doi: 10.1002/pds.4809. [Epub ahead of print] Review.

PMID:
31298463
2.

Excess Deaths Attributable to Influenza-Like Illness in the ESRD Population.

Gilbertson DT, Rothman KJ, Chertow GM, Bradbury BD, Brookhart MA, Liu J, Winkelmayer WC, Stürmer T, Monda KL, Herzog CA, Ashfaq A, Collins AJ, Wetmore JB.

J Am Soc Nephrol. 2019 Feb;30(2):346-353. doi: 10.1681/ASN.2018060581. Epub 2019 Jan 24.

PMID:
30679380
3.

Estimating the Effect of Preventable Treatment Discontinuation on Health Outcomes.

Brookhart MA, Reams D, Dluzniewski PJ, Kshirsagar A, Walsh L, Bradbury BD.

Epidemiology. 2018 Jan;29(1):134-141. doi: 10.1097/EDE.0000000000000766.

PMID:
28991002
4.

Changes in the use of erythropoiesis-stimulating agents (ESAs) and red blood cell transfusion in patients with cancer amidst regulatory and reimbursement changes.

Gawade PL, Berlin JA, Henry DH, Tomita D, Brooks BD, Franklin J, Bradbury BD, Critchlow CW.

Pharmacoepidemiol Drug Saf. 2017 Nov;26(11):1357-1366. doi: 10.1002/pds.4293. Epub 2017 Aug 14.

PMID:
28809079
5.

Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US.

Mues KE, Liede A, Liu J, Wetmore JB, Zaha R, Bradbury BD, Collins AJ, Gilbertson DT.

Clin Epidemiol. 2017 May 9;9:267-277. doi: 10.2147/CLEP.S105613. eCollection 2017. Review.

6.

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis.

Block GA, Yusuf AA, Danese MD, Wirtz HS, Hu Y, Do TP, Cooper K, Gilbertson DT, Bradbury BD, Collins AJ.

BMC Nephrol. 2016 Nov 4;17(1):166.

7.

The association between cinacalcet use and missed in-center hemodialysis treatment rate.

Brunelli SM, Sibbel S, Dluzniewski PJ, Cooper K, Bensink ME, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2016 Nov;25(11):1287-1294. doi: 10.1002/pds.4050. Epub 2016 Jun 27.

PMID:
27346298
8.

Geovariation in Fracture Risk among Patients Receiving Hemodialysis.

Wetmore JB, Liu J, Wirtz HS, Gilbertson DT, Cooper K, Nieman KM, Collins AJ, Bradbury BD.

Clin J Am Soc Nephrol. 2016 Aug 8;11(8):1413-21. doi: 10.2215/CJN.11651115. Epub 2016 Jun 7.

9.

Effects of Epoetin Alfa Titration Practices, Implemented After Changes to Product Labeling, on Hemoglobin Levels, Transfusion Use, and Hospitalization Rates.

Molony JT, Monda KL, Li S, Beaubrun AC, Gilbertson DT, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2016 Aug;68(2):266-276. doi: 10.1053/j.ajkd.2016.02.038. Epub 2016 Mar 12.

PMID:
26980607
10.

Epoetin Alfa and Outcomes in Dialysis amid Regulatory and Payment Reform.

Chertow GM, Liu J, Monda KL, Gilbertson DT, Brookhart MA, Beaubrun AC, Winkelmayer WC, Pollock A, Herzog CA, Ashfaq A, Sturmer T, Rothman KJ, Bradbury BD, Collins AJ.

J Am Soc Nephrol. 2016 Oct;27(10):3129-3138. Epub 2016 Feb 25.

11.

Co-trending of parathyroid hormone and phosphate in patients receiving hemodialysis.

Block G, Do TP, Collins AJ, Cooper KC, Bradbury BD.

Clin Nephrol. 2016 Mar;85(3):142-51. doi: 10.5414/CN108629.

PMID:
26784912
12.

Controlling confounding of treatment effects in administrative data in the presence of time-varying baseline confounders.

Gilbertson DT, Bradbury BD, Wetmore JB, Weinhandl ED, Monda KL, Liu J, Brookhart MA, Gustafson SK, Roberts T, Collins AJ, Rothman KJ.

Pharmacoepidemiol Drug Saf. 2016 Mar;25(3):269-77. doi: 10.1002/pds.3922. Epub 2015 Nov 26.

PMID:
26608680
13.

Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design.

Reams BD, Dluzniewski PJ, Do TP, Yue SV, Bradbury BD, Kshirsagar AV, Brookhart MA.

BMC Nephrol. 2015 Oct 29;16:175. doi: 10.1186/s12882-015-0174-6.

14.

Changes in secondary hyperparathyroidism-related biochemical parameters and medication use following parathyroidectomy.

Wetmore JB, Liu J, Do TP, Lowe KA, Ishani A, Bradbury BD, Block GA, Collins AJ.

Nephrol Dial Transplant. 2016 Jan;31(1):103-11. doi: 10.1093/ndt/gfv291. Epub 2015 Aug 19.

PMID:
26292694
15.

Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation.

Brunelli SM, Dluzniewski PJ, Cooper K, Do TP, Sibbel S, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2015 Oct;24(10):1058-67. doi: 10.1002/pds.3845. Epub 2015 Aug 2.

PMID:
26238994
16.

Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: a retrospective cohort analysis.

Wetmore JB, Peng Y, Monda KL, Kats AM, Kim DH, Bradbury BD, Collins AJ, Gilbertson DT.

Am J Nephrol. 2015;41(4-5):354-61. doi: 10.1159/000431335. Epub 2015 Jun 17.

PMID:
26107376
17.

Facility Dialysate Calcium Practices and Clinical Outcomes Among Patients Receiving Hemodialysis: A Retrospective Observational Study.

Brunelli SM, Sibbel S, Do TP, Cooper K, Bradbury BD.

Am J Kidney Dis. 2015 Oct;66(4):655-65. doi: 10.1053/j.ajkd.2015.03.038. Epub 2015 May 23.

PMID:
26015274
18.

Comparative changes in treatment practices and clinical outcomes following implementation of a prospective payment system: the STEPPS study.

Monda KL, Joseph PN, Neumann PJ, Bradbury BD, Rubin RJ.

BMC Nephrol. 2015 May 1;16:67. doi: 10.1186/s12882-015-0059-8.

19.

Red blood cell transfusion, hyperkalemia, and heart failure in advanced chronic kidney disease.

Gill K, Fink JC, Gilbertson DT, Monda KL, Muntner P, Lafayette RA, Petersen J, Chertow GM, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2015 Jun;24(6):654-62. doi: 10.1002/pds.3779. Epub 2015 Apr 22.

PMID:
25903095
20.

Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study.

St Peter WL, Yusuf AA, Do T, Lowe KA, Liu J, Nieman KM, Bradbury BD, Collins AJ.

BMC Nephrol. 2015 Mar 31;16:41. doi: 10.1186/s12882-015-0030-8.

21.

Refining the definition of clinically important mineral and bone disorder in hemodialysis patients.

Danese MD, Halperin M, Lowe KA, Bradbury BD, Do TP, Block GA.

Nephrol Dial Transplant. 2015 Aug;30(8):1336-44. doi: 10.1093/ndt/gfv034. Epub 2015 Mar 27.

22.

Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.

Ishani A, Liu J, Wetmore JB, Lowe KA, Do T, Bradbury BD, Block GA, Collins AJ.

Clin J Am Soc Nephrol. 2015 Jan 7;10(1):90-7. doi: 10.2215/CJN.03520414. Epub 2014 Dec 16.

23.

The authors reply.

Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL.

Kidney Int. 2014 Sep;86(3):649. doi: 10.1038/ki.2014.160. No abstract available.

24.

Response to High rates of death and hospitalization follow bone fracture among hemodialysis patients.

Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL.

Kidney Int. 2013 Jul 31;85(1):166-173. No abstract available.

25.

Development of a standardized transfusion ratio as a metric for evaluating dialysis facility anemia management practices.

Liu J, Li S, Gilbertson DT, Monda KL, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2014 Oct;64(4):608-15. doi: 10.1053/j.ajkd.2014.04.012. Epub 2014 May 10.

PMID:
24820317
26.

Predialysis care and dialysis outcomes in hemodialysis patients with a functioning fistula.

Ishani A, Gilbertson DT, Kim D, Bradbury BD, Collins AJ.

Am J Nephrol. 2014;39(3):238-47. doi: 10.1159/000358843. Epub 2014 Mar 8.

27.

Effect of facility-level hemoglobin concentration on dialysis patient risk of transfusion.

Collins AJ, Monda KL, Molony JT, Li S, Gilbertson DT, Bradbury BD.

Am J Kidney Dis. 2014 Jun;63(6):997-1006. doi: 10.1053/j.ajkd.2013.10.052. Epub 2013 Dec 4.

PMID:
24315770
28.

Red blood cell transfusions and the risk of allosensitization in patients awaiting primary kidney transplantation.

Leffell MS, Kim D, Vega RM, Zachary AA, Petersen J, Hart JM, Rossert J, Bradbury BD.

Transplantation. 2014 Mar 15;97(5):525-33. doi: 10.1097/01.tp.0000437435.19980.8f.

PMID:
24300013
29.

Sensitization from transfusion in patients awaiting primary kidney transplant.

Yabu JM, Anderson MW, Kim D, Bradbury BD, Lou CD, Petersen J, Rossert J, Chertow GM, Tyan DB.

Nephrol Dial Transplant. 2013 Nov;28(11):2908-18. doi: 10.1093/ndt/gft362. Epub 2013 Sep 5.

30.

High rates of death and hospitalization follow bone fracture among hemodialysis patients.

Tentori F, McCullough K, Kilpatrick RD, Bradbury BD, Robinson BM, Kerr PG, Pisoni RL.

Kidney Int. 2014 Jan;85(1):166-73. doi: 10.1038/ki.2013.279. Epub 2013 Jul 31.

31.

RBC transfusions among hemodialysis patients (1999-2010): influence of hemoglobin concentrations below 10 g/dL.

Gilbertson DT, Monda KL, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2013 Nov;62(5):919-28. doi: 10.1053/j.ajkd.2013.05.004. Epub 2013 Jun 28.

PMID:
23815986
32.

Worldwide, mortality risk is high soon after initiation of hemodialysis.

Robinson BM, Zhang J, Morgenstern H, Bradbury BD, Ng LJ, McCullough KP, Gillespie BW, Hakim R, Rayner H, Fort J, Akizawa T, Tentori F, Pisoni RL.

Kidney Int. 2014 Jan;85(1):158-65. doi: 10.1038/ki.2013.252. Epub 2013 Jun 26.

33.

Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients.

Beaubrun AC, Kilpatrick RD, Freburger JK, Bradbury BD, Wang L, Brookhart MA.

J Am Soc Nephrol. 2013 Sep;24(9):1461-9. doi: 10.1681/ASN.2012090916. Epub 2013 Jun 6.

34.

Red blood cell transfusion use in patients with chronic kidney disease.

Gill KS, Muntner P, Lafayette RA, Petersen J, Fink JC, Gilbertson DT, Bradbury BD.

Nephrol Dial Transplant. 2013 Jun;28(6):1504-15. doi: 10.1093/ndt/gfs580. Epub 2013 Feb 6.

PMID:
23389999
35.

Early trends from the Study to Evaluate the Prospective Payment System Impact on Small Dialysis Organizations (STEPPS).

Brunelli SM, Monda KL, Burkart JM, Gitlin M, Neumann PJ, Park GS, Symonian-Silver M, Yue S, Bradbury BD, Rubin RJ.

Am J Kidney Dis. 2013 Jun;61(6):947-56. doi: 10.1053/j.ajkd.2012.11.040. Epub 2013 Jan 15.

PMID:
23332991
36.

Low hemoglobin levels and recurrent falls in U.S. men and women: prospective findings from the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.

Bowling CB, Muntner P, Bradbury BD, Kilpatrick RD, Isitt JJ, Warriner AH, Curtis JR, Judd S, Brown CJ, Allman RM, Warnock DG, McClellan W.

Am J Med Sci. 2013 Jun;345(6):446-54. doi: 10.1097/MAJ.0b013e3182638364.

37.

Geographic variation in CKD prevalence and ESRD incidence in the United States: results from the reasons for geographic and racial differences in stroke (REGARDS) study.

Tanner RM, Gutiérrez OM, Judd S, McClellan W, Bowling CB, Bradbury BD, Safford MM, Cushman M, Warnock D, Muntner P.

Am J Kidney Dis. 2013 Mar;61(3):395-403. doi: 10.1053/j.ajkd.2012.10.018. Epub 2012 Dec 8.

38.

Changing patterns of anemia management in US hemodialysis patients.

Freburger JK, Ng LJ, Bradbury BD, Kshirsagar AV, Brookhart MA.

Am J Med. 2012 Sep;125(9):906-14.e9. doi: 10.1016/j.amjmed.2012.03.011.

PMID:
22938926
39.

Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions.

Kilpatrick RD, Gilbertson D, Brookhart MA, Polley E, Rothman KJ, Bradbury BD.

Pharmacoepidemiol Drug Saf. 2013 Feb;22(2):111-21. doi: 10.1002/pds.3297. Epub 2012 Jun 4.

PMID:
22674782
40.

Confounding and control of confounding in nonexperimental studies of medications in patients with CKD.

Bradbury BD, Gilbertson DT, Brookhart MA, Kilpatrick RD.

Adv Chronic Kidney Dis. 2012 Jan;19(1):19-26. doi: 10.1053/j.ackd.2012.01.001. Review.

PMID:
22364797
41.

Association of family history of ESRD, prevalent albuminuria, and reduced GFR with incident ESRD.

McClellan WM, Warnock DG, Judd S, Muntner P, Patzer RE, Bradbury BD, McClure LA, Newsome BB, Howard G.

Am J Kidney Dis. 2012 Jan;59(1):25-31. doi: 10.1053/j.ajkd.2011.09.018. Epub 2011 Nov 10.

42.

Albuminuria, kidney function, and the incidence of cognitive impairment among adults in the United States.

Kurella Tamura M, Muntner P, Wadley V, Cushman M, Zakai NA, Bradbury BD, Kissela B, Unverzagt F, Howard G, Warnock D, McClellan W.

Am J Kidney Dis. 2011 Nov;58(5):756-63. doi: 10.1053/j.ajkd.2011.05.027. Epub 2011 Aug 4.

43.

Hospitalization risks related to vascular access type among incident US hemodialysis patients.

Ng LJ, Chen F, Pisoni RL, Krishnan M, Mapes D, Keen M, Bradbury BD.

Nephrol Dial Transplant. 2011 Nov;26(11):3659-66. doi: 10.1093/ndt/gfr063. Epub 2011 Mar 3.

PMID:
21372255
44.

The effect of altitude change on anemia treatment response in hemodialysis patients.

Brookhart MA, Bradbury BD, Avorn J, Schneeweiss S, Winkelmayer WC.

Am J Epidemiol. 2011 Apr 1;173(7):768-77. doi: 10.1093/aje/kwq423. Epub 2011 Feb 23.

45.

Changes in erythropoiesis-stimulating agent (ESA) dosing and haemoglobin levels in US non-dialysis chronic kidney disease patients between 2005 and 2009.

Regidor D, McClellan WM, Kewalramani R, Sharma A, Bradbury BD.

Nephrol Dial Transplant. 2011 May;26(5):1583-91. doi: 10.1093/ndt/gfq573. Epub 2010 Sep 22.

PMID:
20861195
46.

Hemoglobin variability and mortality: confounding by disease severity.

Weinhandl ED, Peng Y, Gilbertson DT, Bradbury BD, Collins AJ.

Am J Kidney Dis. 2011 Feb;57(2):255-65. doi: 10.1053/j.ajkd.2010.06.013.

PMID:
20801571
47.

Transfusion burden among patients with chronic kidney disease and anemia.

Lawler EV, Bradbury BD, Fonda JR, Gaziano JM, Gagnon DR.

Clin J Am Soc Nephrol. 2010 Apr;5(4):667-72. doi: 10.2215/CJN.06020809. Epub 2010 Mar 18.

48.

Comparative mortality risk of anemia management practices in incident hemodialysis patients.

Brookhart MA, Schneeweiss S, Avorn J, Bradbury BD, Liu J, Winkelmayer WC.

JAMA. 2010 Mar 3;303(9):857-64. doi: 10.1001/jama.2010.206.

PMID:
20197532
49.

Prevalence and severity of chronic kidney disease and anemia in the nursing home population.

McClellan WM, Resnick B, Lei L, Bradbury BD, Sciarra A, Kewalramani R, Ouslander JG.

J Am Med Dir Assoc. 2010 Jan;11(1):33-41. doi: 10.1016/j.jamda.2009.07.003. Epub 2009 Nov 6.

PMID:
20129213
50.

Initiation of anaemia management in patients with chronic kidney disease not on dialysis in the Veterans Health Administration.

Lawler EV, Gagnon DR, Fink J, Seliger S, Fonda J, Do TP, Gaziano JM, Bradbury BD.

Nephrol Dial Transplant. 2010 Jul;25(7):2237-44. doi: 10.1093/ndt/gfp758. Epub 2010 Jan 18.

PMID:
20083469

Supplemental Content

Loading ...
Support Center